Pöllänen et al., 1987 - Google Patents
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cellsPöllänen et al., 1987
View PDF- Document ID
- 4670215311999367775
- Author
- Pöllänen J
- Saksela O
- Salonen E
- Andreasen P
- Nielsen L
- Danø K
- Vaheri A
- Publication year
- Publication venue
- The Journal of cell biology
External Links
Snippet
We studied the immunocytochemical localization of urokinase-type plasminogen activator (u- PA) and the type 1 plasminogen activator inhibitor (PAI-1) in human fibroblasts and sarcoma cells, using both polyclonal and monoclonal antibodies. The u-PA was found to be located at …
- 210000004027 cells 0 title abstract description 142
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pöllänen et al. | Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells | |
| Levin et al. | Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells. | |
| Nielsen et al. | Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells-inhibitor neutralization and one-step affinity purification | |
| Knudsen et al. | Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. | |
| Ossowski et al. | In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. | |
| Mimuro et al. | Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor | |
| Myöhänen et al. | Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. | |
| Mignatti et al. | Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. | |
| Pöllänen et al. | Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. | |
| Schäfer et al. | Plasminogen activation in healing human wounds. | |
| Parkkinen et al. | Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. | |
| Fujimoto et al. | A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies | |
| Larsson et al. | Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. | |
| Mazzieri et al. | Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants | |
| Liotta et al. | Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin | |
| Saksela et al. | Urokinase‐type plasminogen activator and its inhibitor secreted by cultured human monocyte‐macrophages | |
| Belloc et al. | The effect of platelets on invasiveness and protease production of human mammary tumor cells | |
| Duffy et al. | Plasminogen activator and cancer | |
| Lacave et al. | Characterization of a plasminogen activator and its inhibitor in human mesangial cells | |
| Booth et al. | Plasminogen activator inhibitor from human endothelial cells: purification and partial characterization | |
| Angles-Cano et al. | Production of monoclonal antibodies to the high fibrin-affinity, tissue-type plasminogen activator of human plasma. Demonstration of its endothelial origin by immunolocalization | |
| Kono et al. | Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors | |
| Hayashi et al. | Pathogenesis of corneal epithelial defects: role of plasminogen activator | |
| Rondeau et al. | Urokinase synthesis and binding by glomerular epithelial cells in culture | |
| Persky et al. | Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion |